In 1984, Kelly Biotechnology started as a small biotech company. However, under the persistence of its founders, the company gradually grew. Today, it has become a professional manufacturer of biological products. With a total area of 581,175 square meters, the company has a registered capital of 30 million yuan. After years of development, the company's total assets have now reached 560 million yuan, with self-owned funds exceeding 290 million yuan, demonstrating substantial strength. Kelly Biotechnology operates four subsidiary factories and one business department, employing over 280 staff members. Among them are more than 35 specialized technical personnel and 62 management staff, who serve as strong pillars for the company's successful development. The company's main business involves using advanced technical processes to decompose and distill fusel oil to produce various alcohol products. These products include butanol, isoamyl alcohol, n-propanol, mixed alcohols, 3-methylbutanol, 2-methylbutanol, and more. Annually, the company can produce over 20,000 tons of natural bio-based alcohol products, with an output value of up to 360 million yuan and a profit and tax contribution of 110 million yuan. With its innovative and unique technology, Kelly Biotechnology has received multiple invention patents and honors in science and technology awards. These accolades are a full affirmation of their continuous efforts. The market for their products has expanded to domestic, Southeast Asian, and European and American markets, with a certain market share domestically and broad prospects for future growth. The glorious achievements of Kelly Biotechnology are inseparable from the collective efforts of all employees, who consistently uphold the pursuit of technological advancement and a belief in quality. On the path of continuous innovation and development, they write one success story after another with their wisdom and diligence. Shandong Kelly Biotechnology Co., Ltd. will continue to adhere to the principles of innovation and progress in the future, making due contributions to the development of the biotechnology industry.